Last reviewed · How we verify
Increasing doses of GLP-1 — Competitive Intelligence Brief
phase 1
Small molecule
Live · refreshed every 30 min
Target snapshot
Increasing doses of GLP-1 (Increasing doses of GLP-1) — University Hospital, Basel, Switzerland.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| Increasing doses of GLP-1 TARGET | Increasing doses of GLP-1 | University Hospital, Basel, Switzerland | phase 1 |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- Increasing doses of GLP-1 CI watch — RSS
- Increasing doses of GLP-1 CI watch — Atom
- Increasing doses of GLP-1 CI watch — JSON
- Increasing doses of GLP-1 alone — RSS
Cite this brief
Drug Landscape (2026). Increasing doses of GLP-1 — Competitive Intelligence Brief. https://druglandscape.com/ci/increasing-doses-of-glp-1. Accessed 2026-05-17.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab